Lim Bryant David

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$35,573.50
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Lim Bryant David

According to the SEC Form 4 filings, Lim Bryant David, being in a position of

  1. CLO, Interim CFO, Corp Sec. at Prelude Therapeutics Incorporated,
    оver the last 12 months, has bought 25000 shares for $22,638, and sold 0 shares,
    over all time since 2023-05-24, has bought 27400 shares for $35,574, and sold 0 shares.

The largest purchase of all time was on 2024-12-19 and amounted to 25000 shares of Prelude Therapeutics Incorporated for $22,638.

Biography of Lim Bryant David

No biography is available at this moment.

2024-12-19PurchasePrelude Therapeutics Incorporated
PRLD
CLO, Interim CFO, Corp Sec.
25,000
0.0452%
$0.91$22,638+28.12%
2023-05-24PurchasePrelude Therapeutics Incorporated
PRLD
Chief Legal Officer, Corp Sec.
2,400
0.0053%
$5.39$12,936-26.36%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.